White Paper

IND Ready Is Not Phase 2 Ready

Download

Download White Paper

The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.

Share

Related Resources

All Resources

Supply chain analyst monitors global shipment routes on digital maps to help protect clinical trial supply chains from geopolitical risk and disruptions.

post

Protecting Clinical Trial Supply Chains from Geopolitical Risk

Read More

Commissioner’s National Priority Voucher (CNPV) Pilot Program, Syner-G

white-paper

Commissioner’s National Priority Voucher (CNPV) Pilot Program

Read More

Researcher in a lab coat uses a tablet touchscreen in a laboratory setting to monitor digital data and workflows for clinical trial supply chain operations.

post

Digital QMS & Emerging AI Tools in Pharmaceutical Quality Management

Read More

What You Should Know About the FDA’s New CNPV Pilot Program, Syner-G

infographic

What You Should Know About the FDA’s New CNPV Pilot Program

Read More

Let's move from science to success.